Cited 1 times in
Association Between Curative Treatment after Transarterial Radioembolization and Better Survival Outcomes in Patients with Hepatocellular Carcinoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김도영 | - |
dc.contributor.author | 김범경 | - |
dc.contributor.author | 김승업 | - |
dc.contributor.author | 김윤아 | - |
dc.contributor.author | 박준용 | - |
dc.contributor.author | 안상훈 | - |
dc.contributor.author | 이재승 | - |
dc.contributor.author | 전미영 | - |
dc.date.accessioned | 2021-04-29T17:33:51Z | - |
dc.date.available | 2021-04-29T17:33:51Z | - |
dc.date.issued | 2021-03 | - |
dc.identifier.issn | 0735-7907 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/182410 | - |
dc.description.abstract | Transarterial radioembolization (TARE) is one of the therapeutic options for hepatocellular carcinoma (HCC). This study aimed to investigate the predictors and prognostic values of achieving curative treatments after TARE. Overall, 143 patients with intrahepatic HCC treated with TARE between 2011 and 2017 were recruited from two Korean tertiary institutes. Twenty-seven patients received curative treatments after TARE. Younger age than 65 years and AFP of ≤200 ng/mL independently predicted the increased probability of achieving curative treatment after TARE, and the curative treatment after TARE provided a survival benefit in patients with intrahepatic HCC. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Taylor & Francis | - |
dc.relation.isPartOf | CANCER INVESTIGATION | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Carcinoma, Hepatocellular / diagnostic imaging | - |
dc.subject.MESH | Carcinoma, Hepatocellular / mortality | - |
dc.subject.MESH | Carcinoma, Hepatocellular / therapy* | - |
dc.subject.MESH | Chemoradiotherapy | - |
dc.subject.MESH | Embolization, Therapeutic / methods* | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Kaplan-Meier Estimate | - |
dc.subject.MESH | Liver Neoplasms / diagnostic imaging | - |
dc.subject.MESH | Liver Neoplasms / mortality | - |
dc.subject.MESH | Liver Neoplasms / therapy* | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Retrospective Studies | - |
dc.subject.MESH | Treatment Outcome | - |
dc.subject.MESH | Yttrium Radioisotopes | - |
dc.title | Association Between Curative Treatment after Transarterial Radioembolization and Better Survival Outcomes in Patients with Hepatocellular Carcinoma | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Yuna Kim | - |
dc.contributor.googleauthor | Han Ah Lee | - |
dc.contributor.googleauthor | Jae Seung Lee | - |
dc.contributor.googleauthor | Mi Young Jeon | - |
dc.contributor.googleauthor | Beom Kyung Kim | - |
dc.contributor.googleauthor | Jun Yong Park | - |
dc.contributor.googleauthor | Do Young Kim | - |
dc.contributor.googleauthor | Sang Hoon Ahn | - |
dc.contributor.googleauthor | Soon Ho Um | - |
dc.contributor.googleauthor | Yeon Seok Seo | - |
dc.contributor.googleauthor | Seung Up Kim | - |
dc.identifier.doi | 10.1080/07357907.2020.1870126 | - |
dc.contributor.localId | A00385 | - |
dc.contributor.localId | A00487 | - |
dc.contributor.localId | A00654 | - |
dc.contributor.localId | A06043 | - |
dc.contributor.localId | A01675 | - |
dc.contributor.localId | A02226 | - |
dc.contributor.localId | A05963 | - |
dc.contributor.localId | A05405 | - |
dc.relation.journalcode | J00446 | - |
dc.identifier.eissn | 1532-4192 | - |
dc.identifier.pmid | 33356630 | - |
dc.identifier.url | https://www.tandfonline.com/doi/full/10.1080/07357907.2020.1870126 | - |
dc.subject.keyword | TARE | - |
dc.subject.keyword | Yttrium-90 | - |
dc.subject.keyword | curative treatment | - |
dc.subject.keyword | hepatocellular carcinoma | - |
dc.subject.keyword | radioembolization | - |
dc.contributor.alternativeName | Kim, Do Young | - |
dc.contributor.affiliatedAuthor | 김도영 | - |
dc.contributor.affiliatedAuthor | 김범경 | - |
dc.contributor.affiliatedAuthor | 김승업 | - |
dc.contributor.affiliatedAuthor | 김윤아 | - |
dc.contributor.affiliatedAuthor | 박준용 | - |
dc.contributor.affiliatedAuthor | 안상훈 | - |
dc.contributor.affiliatedAuthor | 이재승 | - |
dc.contributor.affiliatedAuthor | 전미영 | - |
dc.citation.volume | 39 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 274 | - |
dc.citation.endPage | 283 | - |
dc.identifier.bibliographicCitation | CANCER INVESTIGATION, Vol.39(3) : 274-283, 2021-03 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.